To understand whether the increased surface availability and constitutive endocytosis of EGFR in spheroids translated into an increased ADC effect, we next treated 2D and 3D glioma cultures with an anti-EGFR antibody precomplexed with a secondary antibody-monomethyl auristatin F toxin conjugate. The gene discussed is EGFR; the disease is glioma.